Lupin gets tentative nod from US FDA for Enzalutamide tablets
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
NPPA integrates Pharma Jan Samadhan with Pharma Sahi Daam portal
The unified platform enables users to check the prices of scheduled and non-scheduled medicines and lodge complaints related to…
Shilpa Biologicals commissions ADC GMP manufacturing facility in Dharwad
The company informed that the facility which is fully operational, is designed to meet global regulatory approval standards
Long-term growth and credibility of India’s hair restoration industry will depend on strong…
India's hair restoration industry has witnessed significant growth over the last decade. What are the key factors driving this…
Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene…
Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; administered orally twice daily
Concord Biotech clears Kenya, Uganda regulatory inspection
The inspection was conducted from June 18 to June 24, 2026
CDSCO clarifies regulatory pathway for formulation intermediates
According to the circular, formulation intermediates intended for use in modified-release dosage forms, including sustained…
Apexon signs strategic collaboration agreement with AWS for AI and cloud solutions in healthcare and…
Collaboration to focus on agentic AI deployment, cloud modernisation and digital engineering for healthcare and life sciences…
BDR Pharma launches XATRONEM-AV for multidrug-resistant Gram-negative infections
Aztreonam and Avibactam injection introduced for the treatment of serious bacterial infections in hospitalised patients
Dr Reddy’s whitepaper outlines roadmap for strengthening India’s translational research ecosystem
Report identifies priorities to improve translational research through collaboration, funding, regulation and clinical data…